The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A pilot phase II study of digoxin in patients with recurrent prostate cancer as evident by a rising PSA.
Jianqing Lin
No relevant relationships to disclose
Jean H. Hoffman-Censits
No relevant relationships to disclose
Danielle Duffy
No relevant relationships to disclose
Inna Chervoneva
No relevant relationships to disclose
Deborah Kilpatrick
No relevant relationships to disclose
Brooke Kennedy
No relevant relationships to disclose
Edouard John Trabulsi
No relevant relationships to disclose
Costas D. Lallas
No relevant relationships to disclose
Leonard G. Gomella
No relevant relationships to disclose
Thomas Force
No relevant relationships to disclose
William Kevin Kelly
No relevant relationships to disclose